EZ Medical is one of two business segments of the Eckert & Ziegler group. Decades of experience, a team of highly qualified employees and a strong network of international partners are what defines us and our work.
Our headquarters are located in Berlin, Germany.
We are a reliable partner for you and your project. To this end we pooled multifaceted expertise from various areas to provide a comprehensive range of products and services in a wide field of activity:
Although EZ Medical consists of multiple companies, we act in concert. Internal exchange of knowledge is the base of our daily operations and the key to our success. Our 330 colleagues cooperate to offer individual, valuable and innovative solutions. The highly qualified team comprises expertise in a multitude of areas. These professional skills combined with short communication paths make us cope with even the most complex challenges as a team.
Milestones
The beginnings of today’s company go back to the technical department of isotope production at the Nuclear Research Center in Dresden-Rossendorf.
Isotope Technologies Dresden GmbH
1964
1965
Isotope Technologies Dresden GmbH
Process development for the production of Mo-99 and I-131 on the basis of irradiated tellurium dioxide.
Invention of Ru-106 Eye Applicators
Eckert & Ziegler BEBIG GmbH
1969
Spin-off as Wälischmiller Dresden branch from the Central Institute for Nuclear Research.
Isotope Technologies Dresden GmbH
1991
1992
The beginning of Eckert & Ziegler, Berlin
Founding of BEBIG Isotopentechnik und Umweltdiagnostik GmbH (BEBIG GmbH), Berlin by Dr. Andreas Eckert and Jurgen Ziegler
A company that developed production lines, special sources and recycling processes for radioactive materials was arisen.
EUROTOPE development company for isotope technologies mbH, Berlin
1995
Founding of the holding company for a number of specialized subsidiaries.
Eckert & Ziegler Radiation and Medical Technology AG, Berlin
1997
1999
Eckert & Ziegler BEBIG GmbH
Set up of the Seed production.
Registration of FDG-EZAG (Fludeoxyglucose (18F)).
FDG-EZAG
2000
Introduction of the first MultiSource®afterloader.
Eckert & Ziegler BEBIG GmbH
2003
2005
Eckert & Ziegler Europe GmbH
Acquisition of 51% of the shares of f-con Europe GmbH.
Acquisition of 70% of EURO-PET Berlin Zyklotron GmbH, Berlin.
EURO-PET Berlin Zyklotron GmbH, Berlin
2005
POLATOM – complete hot cell complex for I-131 production.
Isotope Technologies Dresden GmbH
2005
2006
External
Registration ofExternal([90Y]Yttrium chloride) in several European countries.
The beginning of our synthesis devices: with theModular-Lab Standard.
Modular-Lab Standard
2006
Change of name to Isotope Technologies Dresden GmbH.
Isotope Technologies Dresden GmbH
2008
2008
Isotope Technologies Dresden GmbH
Entry into the radiopharmaceuticals sector.
Acquisition of the isotope specialist Nuclitec GmbH, Braunschweig.
Eckert & Ziegler Nuclitec GmbH, Braunschweig
2009
TheModular-Lab PharmTraceris a cassette-based solution for routine production.
Modular-Lab PharmTracer
2009
2010
SonoTECH GmbH
Acquisition of SonoTECH GmbH. Development of brachytherapy treatment planning systems in-house starts.
King Faisal Specialist Hospital & Research Centre (Saudi Arabia) – Plant for the production of Tc-99m generators by aseptic loading.
Isotope Technologies Dresden GmbH
2010
BRIT (India) – Plant for the production of Tc99m generators by loading and subsequent autoclaving of the generator columns.
Isotope Technologies Dresden GmbH
2010
2011
Eckert & Ziegler Analytical Equipment
Acquisition of the Analytic Instrumentation and Radiochemistry Equipment Business from American market leader Bioscan, Inc.
Dimitrovgrad (Russia) – production of Mo-99 (from nuclear fission).
Isotope Technologies Dresden GmbH
2011
U.S. market entry and acquisition of Mick Radio-Nuclear Instruments, Inc.
Eckert & Ziegler BEBIG GmbH
2013
2013
Modular-Lab eazy
TheModular-Lab eazyisthe smallest automated synthesis system on the market.
Cern – Construction of the ISOLDE Alpha-Gamma Hot Cell for processing and disassembly of irradiated alpha-gamma targets.
Isotope Technologies Dresden GmbH
2013
Approval of the world’s first68Ge/68Ga radionuclide generatorfor positron emission tomography (PET) in the diagnosis of cancer – theGalliaPharm®.
GalliaPharm®
2014
2014
Isotope Technologies Dresden GmbH
MURR (USA) – first plant in the USA – for the production ofI-131 based on irradiated tellurium dioxide.
Registration ofGalliaPharm®as a drug product in 12 countries of the European Union finalized.
GalliaPharm®
2015
FDA Inspection ofGalliaPharm®manufacturing facility in Berlin successfully passed.
GalliaPharm®
2015
2016
AAA’s NETSPOT®
AAA’s NETSPOT®Gallium Ga 68 dotatate kit approval in the USA linksGalliaPharm®as the source of the68Ga.
European Commission has approved SomaKit TOC™ (AAA).
SomaKit OCD™
2016
HZDR (Germany) – PET hot cell line for synthesis, target handling/distribution and filling of PET radiopharmaceuticals.
Isotope Technologies Dresden GmbH
2016
2017
Eckert & Ziegler Radiopharma GmbH
Eckert & Ziegler Radiopharma sells its cyclotron division to Alliance Medical.
Launch ofIsoSeed® I25.S17plusfor brain tumor treatment.
Eckert & Ziegler BEBIG GmbH
2017
Acquisition of WOLF-Medizintechnik GmbH (WOmed), a manufacturer of X-ray devices.
WOLF Medical Technology GmbH
2017
2017
Isotope Technologies Dresden GmbH
Acquisition & rebranding by Eckert & Ziegler Strahlen- und Medizintechnik AG.
VTT (Finland) – Special facility built in close cooperation with VTT.
Isotope Technologies Dresden GmbH
2017
Launch of a shielded safety cabinet designed for the application of Tc-99m and Ga-68 and for ergonomic working.
Isotope Technologies Dresden GmbH
2018
2018
KitLab
KitLabis a fully automated and user-friendly stand-alone device forsafe processing of cold kits.
Chinese joint venture TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd. founded.
Eckert & Ziegler
2018
Construction of a production line for Lu-177 radiopharmaceuticals at the Eckert & Ziegler Radiopharma facility in Braunschweig, Germany.
Isotope Technologies Dresden GmbH
2018
2019
GalliaPharm®
Additional production capacities forGalliaPharm®released by supervisory authorities.
Construction of a production line for Th-227 radiopharmaceuticals at the Eckert & Ziegler Radiopharma facility in Braunschweig, Germany.
Isotope Technologies Dresden GmbH
2019
Paris-177starts its commercial production.
Paris-177
2020
2020
Nuclear Medicine Europe
Eckert & Ziegler joinsNuclear Medicine Europe– the industry association.
Construction of a new production area with hot cells for active ingredient production.
Isotope Technologies Dresden GmbH
2020
Recovery of Ge-68/Ga-68 at the Eckert & Ziegler Radiopharma facility in Berlin.
Isotope Technologies Dresden GmbH
2020
2021
Eckert & Ziegler in Wilmington
A new cGMP facility for the contract manufacturing of radiopharmaceuticals and more in USA.
Extension of its cGMP production site in Berlin, Germany, with a new production facility.
Eckert & Ziegler Berlin
2021
Milestones
1964
2021
1964
Isotope Technologies Dresden GmbH
The beginnings of today’s company go back to the technical department of isotope production at the Nuclear Research Center in Dresden-Rossendorf.
1965
Isotope Technologies Dresden GmbH
Process development for the production of Mo-99 and I-131 on the basis of irradiated tellurium dioxide.
1969
Eckert & Ziegler BEBIG GmbH
Invention of Ru-106 Eye Applicators
1991
Isotope Technologies Dresden GmbH
Spin-off as Wälischmiller Dresden branch from the Central Institute for Nuclear Research.
1992
The beginning of Eckert & Ziegler, Berlin
Founding of BEBIG Isotopentechnik und Umweltdiagnostik GmbH (BEBIG GmbH), Berlin by Dr. Andreas Eckert and Jurgen Ziegler
1995
EUROTOPE development company for isotope technologies mbH, Berlin
A company that developed production lines, special sources and recycling processes for radioactive materials was arisen.
1997
Eckert & Ziegler Radiation and Medical Technology AG, Berlin
Founding of the holding company for a number of specialized subsidiaries.
1999
Eckert & Ziegler BEBIG GmbH
Set up of the Seed production.
2000
FDG-EZAG
Registration of FDG-EZAG (Fludeoxyglucose (18F)).
2003
Eckert & Ziegler BEBIG GmbH
Introduction of the first MultiSource®afterloader.
2005
Eckert & Ziegler Europe GmbH
Acquisition of 51% of the shares of f-con Europe GmbH.
2005
EURO-PET Berlin Zyklotron GmbH, Berlin
Acquisition of 70% of EURO-PET Berlin Zyklotron GmbH, Berlin.
2005
Isotope Technologies Dresden GmbH
POLATOM – complete hot cell complex for I-131 production.
2006
External
Registration ofExternal([90Y]Yttrium chloride) in several European countries.
2006
Modular-Lab Standard
The beginning of our synthesis devices: with theModular-Lab Standard.
2008
Isotope Technologies Dresden GmbH
Change of name to Isotope Technologies Dresden GmbH.
2008
Isotope Technologies Dresden GmbH
Entry into the radiopharmaceuticals sector.
2009
Eckert & Ziegler Nuclitec GmbH, Braunschweig
Acquisition of the isotope specialist Nuclitec GmbH, Braunschweig.
2009
Modular-Lab PharmTracer
TheModular-Lab PharmTraceris a cassette-based solution for routine production.
2010
SonoTECH GmbH
Acquisition of SonoTECH GmbH. Development of brachytherapy treatment planning systems in-house starts.
2010
Isotope Technologies Dresden GmbH
King Faisal Specialist Hospital & Research Centre (Saudi Arabia) – Plant for the production of Tc-99m generators by aseptic loading.
2010
Isotope Technologies Dresden GmbH
BRIT (India) – Plant for the production of Tc99m generators by loading and subsequent autoclaving of the generator columns.
2011
Eckert & Ziegler Analytical Equipment
Acquisition of the Analytic Instrumentation and Radiochemistry Equipment Business from American market leader Bioscan, Inc.
2011
Isotope Technologies Dresden GmbH
Dimitrovgrad (Russia) – production of Mo-99 (from nuclear fission).
2013
Eckert & Ziegler BEBIG GmbH
U.S. market entry and acquisition of Mick Radio-Nuclear Instruments, Inc.
2013
Modular-Lab eazy
TheModular-Lab eazyisthe smallest automated synthesis system on the market.
2013
Isotope Technologies Dresden GmbH
Cern – Construction of the ISOLDE Alpha-Gamma Hot Cell for processing and disassembly of irradiated alpha-gamma targets.
2014
GalliaPharm®
Approval of the world’s first68Ge/68Ga radionuclide generatorfor positron emission tomography (PET) in the diagnosis of cancer – theGalliaPharm®.
2014
Isotope Technologies Dresden GmbH
MURR (USA) – first plant in the USA – for the production ofI-131 based on irradiated tellurium dioxide.
2015
GalliaPharm®
Registration ofGalliaPharm®as a drug product in 12 countries of the European Union finalized.
2015
GalliaPharm®
FDA Inspection ofGalliaPharm®manufacturing facility in Berlin successfully passed.
2016
AAA’s NETSPOT®
AAA’s NETSPOT®Gallium Ga 68 dotatate kit approval in the USA linksGalliaPharm®as the source of the68Ga.
2016
SomaKit OCD™
European Commission has approved SomaKit TOC™ (AAA).
2016
Isotope Technologies Dresden GmbH
HZDR (Germany) – PET hot cell line for synthesis, target handling/distribution and filling of PET radiopharmaceuticals.
2017
Eckert & Ziegler Radiopharma GmbH
Eckert & Ziegler Radiopharma sells its cyclotron division to Alliance Medical.
2017
Eckert & Ziegler BEBIG GmbH
Launch ofIsoSeed® I25.S17plusfor brain tumor treatment.
2017
WOLF Medical Technology GmbH
Acquisition of WOLF-Medizintechnik GmbH (WOmed), a manufacturer of X-ray devices.
2017
Isotope Technologies Dresden GmbH
Acquisition & rebranding by Eckert & Ziegler Strahlen- und Medizintechnik AG.
2017
Isotope Technologies Dresden GmbH
VTT (Finland) – Special facility built in close cooperation with VTT.
2018
Isotope Technologies Dresden GmbH
Launch of a shielded safety cabinet designed for the application of Tc-99m and Ga-68 and for ergonomic working.
2018
KitLab
KitLabis a fully automated and user-friendly stand-alone device forsafe processing of cold kits.
2018
Eckert & Ziegler
Chinese joint venture TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd. founded.
2018
Isotope Technologies Dresden GmbH
Construction of a production line for Lu-177 radiopharmaceuticals at the Eckert & Ziegler Radiopharma facility in Braunschweig, Germany.
2019
GalliaPharm®
Additional production capacities forGalliaPharm®released by supervisory authorities.
2019
Isotope Technologies Dresden GmbH
Construction of a production line for Th-227 radiopharmaceuticals at the Eckert & Ziegler Radiopharma facility in Braunschweig, Germany.
2020
Paris-177
Paris-177starts its commercial production.
2020
Nuclear Medicine Europe
Eckert & Ziegler joinsNuclear Medicine Europe– the industry association.
2020
Isotope Technologies Dresden GmbH
Construction of a new production area with hot cells for active ingredient production.
2020
Isotope Technologies Dresden GmbH
Recovery of Ge-68/Ga-68 at the Eckert & Ziegler Radiopharma facility in Berlin.
2021
Eckert & Ziegler in Wilmington
A new cGMP facility for the contract manufacturing of radiopharmaceuticals and more in USA.
2021
Eckert & Ziegler Berlin
Extension of its cGMP production site in Berlin, Germany, with a new production facility.
Contact Us
The Medical BulletinSubscribe and stay updated
Are you interested in receiving the latest news on our products and recent developments? Do you want to stay updated regarding upcoming events? Our newsletter will be sent regularly and you can unsubscribe anytime.
SUBSCRIBE TO OUR NEWSLETTER
FAQs
How would you describe the US healthcare system today? ›
The US healthcare system does not provide universal coverage and can be defined as a mixed system, where publicly financed government Medicare and Medicaid (discussed here) health coverage coexists with privately financed (private health insurance plans) market coverage.
What is good about the US healthcare system? ›The advanced medical milieu that Americans enjoy has led to the world's best cancer survival rates, a life expectancy for those over 80 that is actually greater than anywhere else, and lower mortality rates for heart attacks and strokes than in comparable countries.
What would you recommend as to how do you improve the US healthcare system? ›- Focus on Improving Health. ...
- Tackle Racial Disparities. ...
- Expand Telehealth and In-Home Hospital Services. ...
- Build Integrated Systems. ...
- Adopt Value-Based Care.
- No central governing agency and little integration and coordination.
- Technology-driven deliver system focusing on acute care.
- High in cost, unequal in access, and average in outcome.
- Delivery of health care under imperfect market conditions.
It has a large and well-trained health workforce, a wide range of high-quality medical specialists as well as secondary and tertiary institutions, a robust health sector research program and, for selected services, among the best medical outcomes in the world.
What part of the US healthcare system is the best? ›Hawaii is the top state for health care in the U.S. It has the best health outcomes in the country, with low preventable death (47 per 100,000 people), diabetes mortality and obesity rates.
What is the most important aspect of healthcare in the United States? ›Patient-centeredness - High-quality care is respectful of and responsive to individual patient preferences, needs, and values and ensures that patient values guide all clinical decisions.
What are six things the US health care system assumes about its patients? ›Katz points out the many assumptions healthcare in the United States makes—that patients can take off of work in the middle of the day to get care, can speak English, are literate, have enough food, have a home with a refrigerator, a bathroom, and a bed where they can sleep without worrying about violence while they ...
What is US Healthcare Solutions? ›US Healthcare Solutions is a hospital & health care company based out of United States.
Who is better solutions for healthcare? ›Better Solutions for Healthcare is focused on educating consumers, employers, and lawmakers on the true drivers behind the rising cost of healthcare and providing market-based solutions that lower healthcare costs for Americans.
How do you answer the biggest problem in healthcare? ›
- Include Facts and Figures to Support Your Opinion.
- Discuss a Potential Solution for the Healthcare Problem.
- Preparation for Your Interview to Demonstrate Confidence.
The ten characteristics of the U.S. healthcare system are: no central governing agency, curative & technology-driven, costly, unequal, average outcome, imperfect market conditions, government subsidizes private sector, fusion of market & social justice, multiple players & balance of power, quest for integration access ...
What are the 3 types of healthcare systems available in the USA? ›There are four basic designs healthcare systems follow: the Beveridge model, the Bismarck model, the national health insurance model, and the out-of-pocket model. The U.S. uses all four of these models for different segments of its residents and citizens.
What are the 4 purposes of health care? ›Medical care has several important functions other than restoring or maintaining health. These other functions are assessment and certification of health status, prognostication, segregation of the ill to limit communication of illness, and helping to cope with the problems of illness--the caring function.
What are the 4 most common types of managed health care plans in the USA? ›- Health maintenance organizations (HMOs)
- Preferred provider organizations (PPOs)
- Exclusive provider organizations (EPOs)
- Point-of-service (POS) plans.
- High-deductible health plans (HDHPs), which may be linked to health savings accounts (HSAs)
- Communication skills.
- Positive attitude. A positive attitude can be very helpful when interacting with patients and coworkers. ...
- Time management.
- Flexibility. ...
- Knowledge of HIPAA. ...
- Empathy. ...
- Stress management. ...
- Attention to detail.
Sample answer: "One of my biggest strengths is my ability to manage time efficiently. I know that healthcare professionals are often required to multitask with tight deadlines, which is why I pride myself on being able to prioritize tasks and complete them promptly."
Who benefits from the US healthcare system? ›The federal government provides funding for the national Medicare program for adults age 65 and older and some people with disabilities as well as for various programs for veterans and low-income people, including Medicaid and the Children's Health Insurance Program.
Does the US provide the best healthcare? ›However, despite higher healthcare spending, America's health outcomes are not any better than those in other developed countries. The United States actually performs worse in some common health metrics like life expectancy, infant mortality, and unmanaged diabetes.
Who has the best medical care in the United States? ›| Rank | Publication Name | Score |
|---|---|---|
| 1 | Mayo Clinic - Rochester | 97.50% |
| 2 | Cleveland Clinic | 92.59% |
| 3 | Massachusetts General Hospital | 92.27% |
| 4 | The Johns Hopkins Hospital | 89.95% |
What are the 3 goals of a healthcare system? ›
There are three overarching goals that make up the Triple Aim of healthcare: reducing costs, improving patient health, and improving quality of care.
What are the 5 components of the US healthcare system? ›- Eligibility.
- Department of Defense.
- Veterans Health Administration.
- Private Sector.
- Nonprofit and Volunteer Organizations.
Unlike most developed nations, the US health system does not provide healthcare to the country's entire population. Instead, most citizens are covered by a combination of private insurance and various federal and state programs.
What are the six key characteristics of a high quality healthcare system? ›Quality health services should be: effective; safe; people-centred; timely; equitable; integrated; and efficient.
What is healthcare technology solutions? ›Healthcare technology is any technology, including medical devices, IT systems, algorithms, artificial intelligence (AI), cloud and blockchain, designed to support healthcare organizations.
Is US healthcare a company? ›U.S. Healthcare, Inc. provides health maintenance organizations (HMO'S). The Company provides virtually complete healthcare coverage in exchange for a fixed monthly payment, as well as prescription drug plans, vision care plans, and a dental care plans. U.S. Healthcare serves customers throughout the United States.
Who is the most important in healthcare? ›Every patient is the most important member of the health care team.
Why is healthcare access important? ›Access to comprehensive, quality health care services is important for promoting and maintaining health, preventing and managing disease, reducing unnecessary disability and premature death, and achieving health equity for all Americans. Why is Access to Health Care Important?
Why is healthcare reform important? ›The goal of health reform is to reduce the number of uninsured, making healthcare more affordable and improving quality of care. In context of global health, health reform that takes place in health systems across the world vary depending upon various factors within the nation.
What are the three biggest issues in healthcare today? ›- The High Cost of Health Care. The problem: Perhaps the most pressing issue in health care currently is the high cost of care. ...
- The Concerns of Health Equity. ...
- The Promise (and Pitfalls) of Technology. ...
- The Move Toward Value-Based Care. ...
- The Growing Provider Shortage.
Why should we hire you? ›
“I should be hired for this role because of my relevant skills, experience, and passion for the industry. I've researched the company and can add value to its growth. My positive attitude, work ethics, and long-term goals align with the job requirements, making me a committed and valuable asset to the company.”
What skills can you bring to this role? ›- Communication. Effective communication is essential in any role. ...
- Organisation and planning. ...
- Motivation and enthusiasm. ...
- Initiative. ...
- Teamwork. ...
- Leadership skills. ...
- Problem solving. ...
- Flexibility.
Don Berwick describes six dimensions of quality in health care: safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity.
How has the US healthcare system evolved? ›The evolution of this complex includes the acceptance of the "germ theory" as the cause of disease, professionalization of doctors, technological advancements in treating disease, the rise of great institutions of medical training and healing, and the advent of medical insurance.
How significant is the US health care system to the overall US economy? ›In 2021, the U.S. spent 17.8 percent of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country.
What would universal healthcare look like in the US? ›Under a Medicare for All plan, patients would have complete freedom to choose their doctors, hospitals, and other providers with no cost sharing, including premiums, copayments, and deductibles. Patients would have no out-of-pocket costs except for prescription drugs.
What is the most common health problem in the US today? ›Heart disease and stroke still the leading causes of death for both U.S. men and women.
What is the most common health problem in us? ›- Heart Disease.
- Cancer.
- Chronic Lower Respiratory Diseases (asthma, emphysema, and chronic bronchitis)
- Obesity.
- Alzheimer's Disease.
- Diabetes.
- Substance Abuse.
- Influenza and Pneumonia.
The United States ranks last overall, despite spending far more of its gross domestic product on health care. The U.S. ranks last on access to care, administrative efficiency, equity, and health care outcomes, but second on measures of care process.
What does the future of healthcare look like in the US? ›Our analysis finds that national health expenditure could grow at a rate of 7.1 percent over the next five years from 2022 to 2027, compared with an expected economic growth rate of 4.7 percent. In aggregate, this would equate to healthcare expenditure growth in excess of economic growth of 2.4 percentage points.
Does the United States have the best healthcare in the world? ›
Roughly six-in-ten say health care in this country is average (32%) or below average (29%) compared with other industrialized countries. Conservative Republicans stand out in their positive assessments of U.S. health care. Two-thirds (66%) say America's health care is either the best in the world or above average.
What kind of healthcare does the US have? ›Unlike most developed nations, the US health system does not provide healthcare to the country's entire population. Instead, most citizens are covered by a combination of private insurance and various federal and state programs.
Why should we have free health care? ›Improving the economy. Providing free healthcare would have an enormous impact on the economy. Many people do not work because they have health conditions which they cannot afford to fix. A country with free healthcare would have a stronger economy than those with pricey healthcare.
How much would universal healthcare save us? ›The research team further calculated that in a non-pandemic year, some $438 billion would be saved by single-payer universal health care, like Medicare for All.